Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Endocrine-Disrupting Chemicals and Health Literacy…

U.S. Office of the Assistant Secretary for Health·United States of America

Endocrine-Disrupting Chemicals and Health Literacy Initiative

Rolling / TBD close$253kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Office on Women’s Health is seeking to develop health literacy materials on Endocrine-Disrupting Chemicals (EDCs) with the goal of communicating effectively to Black and African American women. The two main target audiences are: (1) Black or African American women, and (2) people who care for Black or African American women, including healthcare providers and community programs. The recipient will be expected to develop educational handouts and resources identifying EDCs and safe alternatives, as well as education and training to enhance skillsets for providing individualized, culturally competent, effective care. • The recipient will develop educational handouts and resources for Black or African American women. • The recipient will develop education and training for people caring for Black or African American women. • The goal is to communicate effectively to Black and African American women about EDCs. • The project aims to enhance skillsets for providing individualized, culturally competent, effective care.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Jasmin Bush and Candace Marshall

[email protected]

(202) 690-7650

Key dates

Opened
7/30/2021
Closes
Rolling / TBD
Projected award
6/15/2022

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
621999
Solicitation №
WH-AST-22-002

Budget estimate

$253,000

The Award Ceiling is explicitly stated on the source site.

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 67%

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. Food and Drug Administration·United States of America

66% match

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 12/12/2023

U.S. National Institutes of Health·United States of America

65% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

65% match

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closes 11/18/2027Opened 11/20/2024

U.S. National Institutes of Health·United States of America

65% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

65% match

Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Closes 9/25/2028Opened 6/9/2025

U.S. Centers for Disease Control and Prevention - ERA·United States of America

64% match

Health Promotion and Disease Prevention Research Centers: 2027 Special Interest Project Supplements (SIPS)

Closes 4/21/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

64% match

Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)

Closes 1/4/2027Opened 9/14/2026

U.S. Food and Drug Administration·United States of America

64% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

64% match

Discovery Gateway to Reproductive Health Innovation

Closes 9/30/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

63% match

Intervention Research to Improve Native American Health

Closes 10/17/2027Opened 5/7/2026

U.S. Health Resources and Services Administration·United States of America

63% match

Maternal and Child Health Encounters Networks (MCHEK)

Closes 8/31/2028Opened 7/31/2026

U.S. National Institutes of Health·United States of America

63% match

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028Opened 11/12/2024

U.S. National Institutes of Health·United States of America

63% match

Limited Competition: Supporting Programs to Advance Research Knowledge in Environmental Health Sciences (SPARK-EHS) (UE5/T32 - Clinical Trial Not Allowed)

Closes 12/6/2026Opened 6/26/2026

U.S. Centers for Disease Control - NCEH·United States of America

63% match

State Biomonitoring Cooperative Agreement

Closes 5/18/2027Opened 9/22/2026

U.S. National Institutes of Health·United States of America

63% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/23/2023

U.S. National Institutes of Health·United States of America

63% match

Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier

Closes 10/19/2027Opened 7/16/2026

U.S. National Institutes of Health·United States of America

63% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 8/24/2023

U.S. National Institutes of Health·United States of America

63% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. Department Of Health And Human Services·United States of America

62% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

62% match

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Closes 5/7/2027Opened 8/16/2023

U.S. National Institutes of Health·United States of America

62% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

62% match

Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 3/1/2028Opened 5/14/2025

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Closes 6/15/2027Opened 9/25/2024

U.S. National Institutes of Health·United States of America

62% match

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Closes 10/20/2027Opened 10/22/2024